Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137294009> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2137294009 endingPage "A2" @default.
- W2137294009 startingPage "A2" @default.
- W2137294009 abstract "Highly sensitized (HS) patients seldom have chance to receive kidney transplant. To increase transplantation rate among those population, previous IV immunoglobulin and rituximab desensitization protocol showed good transplant conversion rate, but also carried moderate rate of antibody mediated rejection. Bortezomib, a proteasome inhibitor can control the production of anti-HLA antibodies through plasma cell apoptosis. A single center waitlist desensitization program was employed to facilitate successful kidney transplantation in HS patients group. We prospectively enrolled 23 patients from Jul 2010 to Dec 2013. Desensitization protocol included two doses of IVIG (2 g/kg), single dose of rituximab (375 mg/m 2 , max 500 mg), and 4 days of bortezomib (1.3 mg/m 2 on days 1,3,7 and 9). Anti-HLA class I and II antibodies were determined by Luminex solid phase bead assay at baseline and M2, M3 and M6. We investigated the difference of transplant conversion rate between desensitized HS patients and non-desensitized HS waitlist patients. Also we analyzed the difference of PRA % values and mean fluorescence intensity (MFI) between pre- and post-desensitization serum. Mean age of treatment group was 48.7±11.2 years old. Male to female ratio was 12:11. O+ blood type patients were 34.8% of patients. Mean duration of previous renal replacement therapy were 153.5±65.5 months. Baseline mean class I and II PRA % values were 86±15.3 and 66±34. Baseline class I and II MFI values were 13,893±6,147 and 12,274±6,891. After desensitization, kidney transplant were successfully performed in 34.8% of patients, compared to 13.8% transplant conversion rate among non-desentized HS controls ( p =0.001 by Log-Rank). Among KT recipients, median duration of waiting after desensitization was 3 months with interquartile range 2-8.1 months. Class I PRA % had showed decreased values until 3 months after desensitization. After 6 months, there were no differences between the class I PRA values between pre-desensitization samples and post-desensitization samples. There were no other differences except class I PRA % values. Desensitization protocol were generally well tolerated, with the completion rate of 92% patients. There were no serious adverse events, but moderate adverse event were in 46%, most commonly fever and diarrhea. Highly sensitized waitlist patients are manageable by desensitization protocol including bortezomib." @default.
- W2137294009 created "2016-06-24" @default.
- W2137294009 creator A5007311094 @default.
- W2137294009 creator A5010110196 @default.
- W2137294009 creator A5023097709 @default.
- W2137294009 creator A5034397974 @default.
- W2137294009 creator A5055162846 @default.
- W2137294009 creator A5057361104 @default.
- W2137294009 creator A5065412848 @default.
- W2137294009 creator A5080009275 @default.
- W2137294009 date "2014-06-01" @default.
- W2137294009 modified "2023-09-22" @default.
- W2137294009 title "Successful Interim Outcomes of Bortezomib Desensitization on Highly Sensitized Deceased Donor Kidney Transplant Waitlist Patients" @default.
- W2137294009 doi "https://doi.org/10.1016/j.krcp.2014.05.018" @default.
- W2137294009 hasPublicationYear "2014" @default.
- W2137294009 type Work @default.
- W2137294009 sameAs 2137294009 @default.
- W2137294009 citedByCount "0" @default.
- W2137294009 crossrefType "journal-article" @default.
- W2137294009 hasAuthorship W2137294009A5007311094 @default.
- W2137294009 hasAuthorship W2137294009A5010110196 @default.
- W2137294009 hasAuthorship W2137294009A5023097709 @default.
- W2137294009 hasAuthorship W2137294009A5034397974 @default.
- W2137294009 hasAuthorship W2137294009A5055162846 @default.
- W2137294009 hasAuthorship W2137294009A5057361104 @default.
- W2137294009 hasAuthorship W2137294009A5065412848 @default.
- W2137294009 hasAuthorship W2137294009A5080009275 @default.
- W2137294009 hasBestOaLocation W21372940091 @default.
- W2137294009 hasConcept C126322002 @default.
- W2137294009 hasConcept C126894567 @default.
- W2137294009 hasConcept C159654299 @default.
- W2137294009 hasConcept C170493617 @default.
- W2137294009 hasConcept C203014093 @default.
- W2137294009 hasConcept C2776364478 @default.
- W2137294009 hasConcept C2777478702 @default.
- W2137294009 hasConcept C2779779143 @default.
- W2137294009 hasConcept C2780303639 @default.
- W2137294009 hasConcept C2780653079 @default.
- W2137294009 hasConcept C2911091166 @default.
- W2137294009 hasConcept C64518967 @default.
- W2137294009 hasConcept C71924100 @default.
- W2137294009 hasConcept C90924648 @default.
- W2137294009 hasConceptScore W2137294009C126322002 @default.
- W2137294009 hasConceptScore W2137294009C126894567 @default.
- W2137294009 hasConceptScore W2137294009C159654299 @default.
- W2137294009 hasConceptScore W2137294009C170493617 @default.
- W2137294009 hasConceptScore W2137294009C203014093 @default.
- W2137294009 hasConceptScore W2137294009C2776364478 @default.
- W2137294009 hasConceptScore W2137294009C2777478702 @default.
- W2137294009 hasConceptScore W2137294009C2779779143 @default.
- W2137294009 hasConceptScore W2137294009C2780303639 @default.
- W2137294009 hasConceptScore W2137294009C2780653079 @default.
- W2137294009 hasConceptScore W2137294009C2911091166 @default.
- W2137294009 hasConceptScore W2137294009C64518967 @default.
- W2137294009 hasConceptScore W2137294009C71924100 @default.
- W2137294009 hasConceptScore W2137294009C90924648 @default.
- W2137294009 hasIssue "2" @default.
- W2137294009 hasLocation W21372940091 @default.
- W2137294009 hasOpenAccess W2137294009 @default.
- W2137294009 hasPrimaryLocation W21372940091 @default.
- W2137294009 hasRelatedWork W2222057573 @default.
- W2137294009 hasRelatedWork W2490863177 @default.
- W2137294009 hasRelatedWork W2531870511 @default.
- W2137294009 hasRelatedWork W2550063510 @default.
- W2137294009 hasRelatedWork W2552622579 @default.
- W2137294009 hasRelatedWork W2560389674 @default.
- W2137294009 hasRelatedWork W2563738770 @default.
- W2137294009 hasRelatedWork W2563788357 @default.
- W2137294009 hasRelatedWork W2575554787 @default.
- W2137294009 hasRelatedWork W2579958247 @default.
- W2137294009 hasRelatedWork W2581795823 @default.
- W2137294009 hasRelatedWork W2586575632 @default.
- W2137294009 hasRelatedWork W2589987942 @default.
- W2137294009 hasRelatedWork W2592937350 @default.
- W2137294009 hasRelatedWork W2594121809 @default.
- W2137294009 hasRelatedWork W2980021387 @default.
- W2137294009 hasRelatedWork W2980233799 @default.
- W2137294009 hasRelatedWork W2980272144 @default.
- W2137294009 hasRelatedWork W2981130247 @default.
- W2137294009 hasRelatedWork W3097907465 @default.
- W2137294009 hasVolume "33" @default.
- W2137294009 isParatext "false" @default.
- W2137294009 isRetracted "false" @default.
- W2137294009 magId "2137294009" @default.
- W2137294009 workType "article" @default.